Pinned Tweet
This is really exciting! I'm glad that we have contributed to it. @bowman_rl @roelverhaak #neuro-oncology
14
Congratulations Veronica for the stellar presentation! Special thanks to all the members of the tribunal: Paola Bovolenta, Paco Real, Marta Alonso, @gliomalab, @ggargiul_2020
🎓 Congratutations Verónica Matía on becoming a #PhD holder today #CNIOStopCancer
"Unraveling Novel Transcriptional Networks Regulating Diffuse Midline Glioma Development" 🎉🎉
🙌 Wishing you the best in your career ahead, Verónica
11
Massimo Squatrito retweeted
🎓 Congratutations Verónica Matía on becoming a #PhD holder today #CNIOStopCancer
"Unraveling Novel Transcriptional Networks Regulating Diffuse Midline Glioma Development" 🎉🎉
🙌 Wishing you the best in your career ahead, Verónica
Massimo Squatrito retweeted
#NoticiasCNIO | El equipo de Massimo Squatrito @GlioVis descubre junto a investigadores de @SciMed_unifr el gen master regulator del subtipo de cáncer cerebral con peor pronóstico, el glioblastoma mesenquimal
▶️cnio.es/noticias/descubren-e…
Massimo Squatrito retweeted
#CNIOnews | Massimo Squatrito’s lab @GlioVis and scientists from @SciMed_unifr find the master regulator gene for the mesenchymal subtype of glioblastoma, the brain cancer with the poorest prognosis @eLife
cnio.es/en/news/a-master-reg…
Beyond excited to finally see this published! Very proud of the fantastic work of @c_marqes, our very first PhD student in the lab @CNIOStopCancer. Extremely thankful to our collaborators Stella Carro @SciMed_unifr, @ggargiul_2020 and Erwin Wagner
doi.org/10.7554/eLife.64846
NF1 had been previously shown to be frequently inactivated in mesenchymal GBM. Here we describe that NF1 loss through the activation of the RAS/MAPK signalling leads to the upregulation of the AP1 transcription factor FOSL1 that in turn regulates the mesenchymal gene program
1
5
Last, but not least, thanks to the @SaludISCIII and @SeveBallesteros Foundation for their support!!
3
May is Brain Tumor Awareness Month and today is the 10th anniversary of #Seve Ballesteros' passing. We HAVE TO do more for GBM patients! At the @SeveBallesteros Foundation lab at @CNIOStopCancer we work to identify novel treatments for this devastating disease. #GoGrayinMay
8
Massimo Squatrito retweeted
The combination of temozolomide and dianhydrogalactitol acts synergistically, overcomes the resistance to temozolomide (the first-line treatment for #glioblastoma) and increases survival in animal models
#cancer #research
@SeveBallesteros
cnio.es/en/news/publications…
Massimo Squatrito retweeted
#CNIONews | A team led by Massimo Squatrito @GlioVis, Head of the @SeveBallesteros Foundation Brain Tumour Group at the CNIO, discovers a combination therapy that could improve survival in glioblastomas
A study published in @MCT_AACR
#cancer #research
cnio.es/en/news/publications…
Very excited to share our latest work @MCT_AACR
from the @SeveBallesteros Brain Tumor Group @CNIOStopCancer on overcoming multiple temozolomide resistance mechanisms in glioblastoma
1/n
mct.aacrjournals.org/content…
Congratulations to all the authors and thanks to the @SeveBallesteros Foundation and the @aecc_es for their support!!
2/n
1
Massimo Squatrito retweeted
(1/7) How do #epithelial #cancer #cells regulate their plasticity? In our latest paper, we uncovered chromatin modulators whose loss affects epithelial-mesenchymal interconversion in opposite directions (advances.sciencemag.org/cont…).
Massimo Squatrito retweeted
Recently published #OnlineFirst: Phenotypic mapping of pathological crosstalk between #glioblastoma and innate immune cells by synthetic genetic tracing.
@ggargiul_2020 @MDC_Berlin
https://nitter.cf/t.co/Kgvu2YOkhk
I am very happy that I had the opportunity to give a small contribute to this awesome work from the @ggargiul_2020 lab @MCD_Berlin!!
Phenotypic mapping of pathological crosstalk between glioblastoma and innate immune cells by synthetic genetic tracing cancerdiscovery.aacrjournals…
1
6
3/ Among the different innate immune cell types, the microglia appear to divert glioblastoma cells to a proneural-to-mesenchymal transition which confers therapeutic resistance.
1
1
4/ Stay tuned for more exciting work from the @ggargiul_2020 using the synthetic genetic tracing methodology!!
1
Massimo Squatrito retweeted
Our paper is finally out! We established causal links between clinically relevant covariates and the most aggressive brain tumor state, the mesenchymal glioblastoma. Our technology is generally applicable to complex phenotypes! Thanks to the team/funders! cancerdiscovery.aacrjournals…









